← Back to Search

Mediterranean Diet vs Western Diet for Healthy Eating Habits (Mini-MED Trial)

N/A
Waitlist Available
Led By Nichole Reisdorph, PhD
Research Sponsored by University of Colorado, Denver
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline to endline changes over each 4-week dietary intervention period
Awards & highlights
No Placebo-Only Group

Summary

This trial compares the health benefits of a Mediterranean-style diet of whole grains, fruits and veggies to a typical Western-style diet. Results could inform dietary recommendations to reduce chronic diseases.

Who is the study for?
This trial is for adults aged 30-69 with overweight or obesity, stable weight, and at least three signs of Metabolic Syndrome. Participants must be nonsmokers, maintain consistent physical activity, eat an omnivorous diet not aligned with the Mediterranean style, and agree to biweekly clinic visits. Exclusions include vegetarians/vegans, certain medication users (e.g., warfarin), those with conditions affecting food metabolism (like Crohn's disease), pregnant/lactating women, or anyone planning extended travel.
What is being tested?
The study compares the effects of a Mediterranean-amplified diet versus a typical Western diet on health markers like heart disease risk factors and gut health. It will assess how these diets influence inflammation and metabolomics profiles to inform dietary recommendations aimed at reducing chronic diseases.
What are the potential side effects?
Since this is a dietary intervention study focusing on normal foods rather than medications or supplements, significant side effects are not anticipated. However, changes in diet may cause temporary digestive discomfort as the body adjusts to new eating habits.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline to endline changes over each 4-week dietary intervention period
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline to endline changes over each 4-week dietary intervention period for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Foodomics
Secondary study objectives
Cardiometabolic Health - Adipokines
Cardiometabolic Health - Blood Pressure
Cardiometabolic Health - C-reactive protein
+10 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: mini-MedExperimental Treatment1 Intervention
Mediterranean-amplified habitual/Western (mini-MED) diet, containing 500 kcal/day from Mediterranean target foods (such as raspberries, avocado, red bell pepper, basil, walnuts, chickpeas, oats, salmon).
Group II: WesternActive Control1 Intervention
Habitual/Western (Western) diet, containing 500 kcal/day from non-Mediterranean target foods (such as potato, beef, sour cream, refined grain bread, chocolate dessert).

Find a Location

Who is running the clinical trial?

Purdue UniversityOTHER
233 Previous Clinical Trials
71,356 Total Patients Enrolled
University of Colorado, DenverLead Sponsor
1,805 Previous Clinical Trials
2,822,324 Total Patients Enrolled
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)NIH
2,446 Previous Clinical Trials
4,331,810 Total Patients Enrolled

Media Library

mini-Med Clinical Trial Eligibility Overview. Trial Name: NCT05500976 — N/A
Eating Habits Research Study Groups: mini-Med, Western
Eating Habits Clinical Trial 2023: mini-Med Highlights & Side Effects. Trial Name: NCT05500976 — N/A
mini-Med 2023 Treatment Timeline for Medical Study. Trial Name: NCT05500976 — N/A
~3 spots leftby Mar 2025